Literature DB >> 26705685

Intensity-modulated radiotherapy for head and neck surgeons.

Stanley I Gutiontov1, Edward J Shin2, Benjamin Lok3, Nancy Y Lee3, Ruben Cabanillas4.   

Abstract

The development of intensity-modulated radiotherapy (IMRT) has played a major role in improving outcomes and decreasing morbidity in patients with head and neck cancer. This review addresses this vital modality with a focus on the important role of the head and neck surgeon. The technique as well as its benefits and points of caution are outlined, the definitions of tumor and treatment volumes are discussed, and the dose and fractionation are detailed. Following this are several sections dedicated to the role of the head and neck surgeon in the planning of both definitive and postoperative radiotherapy to the primary site and neck. There is a focus throughout on anatomic and surgical considerations; commonly encountered situations are illustrated. With a deeper understanding of this technique and their own pivotal contribution to target delineation, head and neck surgeons will be poised to expand their role and improve cancer care for their patients.
© 2015 Wiley Periodicals, Inc. Head Neck 38: E2368-E2373, 2016. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer; head and neck; intensity-modulated radiotherapy (IMRT); radiotherapy; target delineation

Mesh:

Year:  2015        PMID: 26705685      PMCID: PMC5024779          DOI: 10.1002/hed.24338

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  55 in total

Review 1.  Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls.

Authors:  William M Mendenhall; Robert J Amdur; Jatinder R Palta
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

2.  Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck.

Authors:  Vincent Grégoire; Avraham Eisbruch; Marc Hamoir; Peter Levendag
Journal:  Radiother Oncol       Date:  2006-04-17       Impact factor: 6.280

3.  Long-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancer.

Authors:  Allen M Chen; Yao Yu; Megan E Daly; D Gregory Farwell; Stanley H Benedict; James A Purdy
Journal:  Head Neck       Date:  2014-03-25       Impact factor: 3.147

Review 4.  Imaging for head and neck cancer.

Authors:  Jesty Abraham
Journal:  Surg Oncol Clin N Am       Date:  2015-04-16       Impact factor: 3.495

Review 5.  Radiation-induced fibrosis: mechanisms and implications for therapy.

Authors:  Jeffrey M Straub; Jacob New; Chase D Hamilton; Chris Lominska; Yelizaveta Shnayder; Sufi M Thomas
Journal:  J Cancer Res Clin Oncol       Date:  2015-04-25       Impact factor: 4.553

6.  A nomogram to predict loco-regional control after re-irradiation for head and neck cancer.

Authors:  Nadeem Riaz; Julian C Hong; Eric J Sherman; Luc Morris; Matthew Fury; Ian Ganly; Tony J C Wang; Weji Shi; Suzanne L Wolden; Andrew Jackson; Richard J Wong; Zhigang Zhang; Shyam D Rao; Nancy Y Lee
Journal:  Radiother Oncol       Date:  2014-06-30       Impact factor: 6.280

7.  Comparative dosimetry of three-phase adaptive and non-adaptive dose-painting IMRT for head-and-neck cancer.

Authors:  Luiza A M Olteanu; Dieter Berwouts; Indira Madani; Werner De Gersem; Tom Vercauteren; Fréderic Duprez; Wilfried De Neve
Journal:  Radiother Oncol       Date:  2014-04-17       Impact factor: 6.280

Review 8.  Radiation-induced second cancers: the impact of 3D-CRT and IMRT.

Authors:  Eric J Hall; Cheng-Shie Wuu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-05-01       Impact factor: 7.038

9.  The hazard of accelerated tumor clonogen repopulation during radiotherapy.

Authors:  H R Withers; J M Taylor; B Maciejewski
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

10.  18F-Fluorodeoxyglucose-PET/CT to evaluate tumor, nodal disease, and gross tumor volume of oropharyngeal and oral cavity cancer: comparison with MR imaging and validation with surgical specimen.

Authors:  Oliver Seitz; Nicole Chambron-Pinho; Markus Middendorp; Rober Sader; Martin Mack; Thomas J Vogl; Sotirios Bisdas
Journal:  Neuroradiology       Date:  2009-10       Impact factor: 2.804

View more
  8 in total

1.  Primary radical ablative surgery and fibula free-flap reconstruction for T4 oral cavity squamous cell carcinoma with mandibular invasion: oncologic and functional results and their predictive factors.

Authors:  Olivier Camuzard; Olivier Dassonville; Marc Ettaiche; Emmanuel Chamorey; Gilles Poissonnet; Riadh Berguiga; Axel Leysalle; Karen Benezery; Frédéric Peyrade; Esma Saada; Raphael Hechema; Anne Sudaka; Juliette Haudebourg; François Demard; José Santini; Alexandre Bozec
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-20       Impact factor: 2.503

2.  Shape constrained fully convolutional DenseNet with adversarial training for multiorgan segmentation on head and neck CT and low-field MR images.

Authors:  Nuo Tong; Shuiping Gou; Shuyuan Yang; Minsong Cao; Ke Sheng
Journal:  Med Phys       Date:  2019-05-06       Impact factor: 4.071

Review 3.  Intensity-modulated radiotherapy for hepatocellular carcinoma: dosimetric and clinical results.

Authors:  Sun Hyun Bae; Won Il Jang; Hee Chul Park
Journal:  Oncotarget       Date:  2017-07-13

Review 4.  IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.

Authors:  Gregory T Wolf; Jeffrey S Moyer; Michael J Kaplan; Jason G Newman; James E Egan; Neil L Berinstein; Theresa L Whiteside
Journal:  Onco Targets Ther       Date:  2018-06-28       Impact factor: 4.147

Review 5.  Nutritional Deficiencies in Radiotherapy-Treated Head and Neck Cancer Patients.

Authors:  Tomasz Powrózek; Joanna Dziwota; Teresa Małecka-Massalska
Journal:  J Clin Med       Date:  2021-02-03       Impact factor: 4.241

6.  Evaluation of computed tomography settings in the context of visualization and discrimination of low dose injections of a novel liquid soft tissue fiducial marker in head and neck imaging.

Authors:  David Steybe; Philipp Poxleitner; Pit Jacob Voss; Marc Christian Metzger; Rainer Schmelzeisen; Fabian Bamberg; Suam Kim; Maximilian Frederik Russe
Journal:  BMC Med Imaging       Date:  2021-10-27       Impact factor: 1.930

7.  Treatment of Fanconi Anemia-Associated Head and Neck Cancer: Opportunities to Improve Outcomes.

Authors:  Rex H Lee; Hyunseok Kang; Sue S Yom; Agata Smogorzewska; Daniel E Johnson; Jennifer R Grandis
Journal:  Clin Cancer Res       Date:  2021-10-01       Impact factor: 12.531

Review 8.  Head and neck cancer: improving outcomes with a multidisciplinary approach.

Authors:  Cristiana Lo Nigro; Nerina Denaro; Anna Merlotti; Marco Merlano
Journal:  Cancer Manag Res       Date:  2017-08-18       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.